When Do Cancer Cases Become a Cancer Cluster? When Do Cancer Cases Become a Cancer Cluster?
Most cancer cases are not considered clusters, but even when a cancer cluster is identified, the cause often remains elusive.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 27, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Okays Liso-cel for Second Line in Large B-cell Lymphoma FDA Okays Liso-cel for Second Line in Large B-cell Lymphoma
The approval expands the indication to include use of the drug after the failure of first-line therapy.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 27, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Cancer May Increase Risk of Type 2 Diabetes Cancer May Increase Risk of Type 2 Diabetes
Certain cancers, particularly pancreatic malignancies, may increase the risk of developing new-onset type 2 diabetes, meaning that oncologists should consider screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 27, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Number of US Cancer Survivors Grew to Over 18 Million Number of US Cancer Survivors Grew to Over 18 Million
This number primarily reflects the effects of a growing and aging population plus advances in early detection and treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 27, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

How FDA Is Working to Improve Oncology Drug Development How FDA Is Working to Improve Oncology Drug Development
The US Food and Drug Administration is working with pharma to reform the accelerated approval process, introduce novel drugs to earlier therapy lines, and make trials more accessible.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 24, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

5 Things Most Physicians Don't Know About Radiation Oncology 5 Things Most Physicians Don't Know About Radiation Oncology
Radiation oncology is often a misunderstood subspecialty. Two radiation oncologists provide a window into the field.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 24, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

No Survival Gain From High-Dose Cytarabine Consolidation in AML No Survival Gain From High-Dose Cytarabine Consolidation in AML
The real-world registry data backup findings from randomized trials comparing high vs intermediate doses. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 23, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Why Is Adhering to Standard of Care So Elusive? Why Is Adhering to Standard of Care So Elusive?
Oncologist Jack West, MD, explores the chasm between recommendations and clinical practice.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 23, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Instead of Staging,'Count the Number of Metastatic Lymph Nodes'Instead of Staging,'Count the Number of Metastatic Lymph Nodes '
The simple process of counting metastatic lymph nodes for determining prognoses for patients with solid tumors tops all the other factors used today, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 22, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Beta Blockers Plus Checkpoint Inhibitor Improve Cancer Control Beta Blockers Plus Checkpoint Inhibitor Improve Cancer Control
Patients with urothelial carcinoma demonstrated improved overall survival as well. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Forget Moonshot: Cancer Patients Right Now Need'Groundshot'Forget Moonshot: Cancer Patients Right Now Need'Groundshot '
While the"Moonshot" aims at the future, a"groundshot" initiative could address the issues facing cancer patients right now by making better use of services that are already available.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

HPV Vaccination'Unmasks' Cervical Lesions From Non-Vax Strains HPV Vaccination'Unmasks' Cervical Lesions From Non-Vax Strains
Clinical trial findings raise concerns amid debate about the future of routine cervical cancer screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Clinical Trials Bounce Back After Pandemic Disruptions Cancer Clinical Trials Bounce Back After Pandemic Disruptions
Clinical trials with cancer patients have slowly regained their momentum and are back to prepandemic levels of activity after serious disruptions during the COVID pandemic.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 20, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Breast Cancer Less Common in Black Women, So Why Do More Die? Breast Cancer Less Common in Black Women, So Why Do More Die?
Black women have a 40% higher chance of dying from breast cancer than non-Hispanic White women. The gap is largely explained by barriers to obtaining medical care, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 20, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Active Treatment or Observation for Localized Prostate Cancer? Active Treatment or Observation for Localized Prostate Cancer?
For patients with intermediate or high-risk localized disease, surgery should be the preferred option, according to a study published as a preprint and not yet peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news